Table 1.
Summary of microarray results in three regions of rat brain after chronic treatment with levetiracetam (Levet) or phenytoin (Phen)
| Drug | Region | No. expressed transcripts | No. transcripts with mean >150% or <67% of control |
No. transcripts >150%or <67% of control and FDR < 0.01 |
|---|---|---|---|---|
| Levet | Pons/medulla | 9,765 | 114 | 65 |
| Phen | Pons/medulla | 9,861 | 45 | 3 |
| Levet | Hippocampus | 9,507 | 48 | 2 |
| Phen | Hippocampus | 9,938 | 223 | 64 |
| Levet | Frontal cortex | 9,771 | 75 | 1 |
| Phen | Frontal cortex | 9,898 | 496 | 327 |
The rat 230.2 GeneChip was used, which contained probe sets representing 16,165 unique transcripts (Dai et al., 2005). Each row represents data from 6 to 7 control or drug-treated animals. The third column shows the number of expressed transcripts with above-background signals in all or all but one control or drug-treated animals. The fourth column shows the number of transcripts with expression >150% or <67% of control as calculated from mean values, whereas the fifth column shows the number of differentially expressed transcripts after controlling for a false discovery rate (FDR) of <0.01 [one-way analysis of variance (ANOVA) with Benjamini and Hochberg (1995) correction for multiple comparisons].